z-logo
open-access-imgOpen Access
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmx170012
Subject(s) - olaparib , medicine , germline , brca mutation , germline mutation , oncology , metastatic breast cancer , breast cancer , mutation , cancer , parp inhibitor , cancer research , genetics , poly adp ribose polymerase , gene , polymerase , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom